High frequency of BRCA1 and BRCA2 germline mutations in Ashkenazi Jewish ovarian cancer patients, regardless of family history

Uziel Beller, David Halle, Raphael Catane, Bella Kaufman, Gila Hornreich, Ephrat Levy-Lahad

Research output: Contribution to journalArticle

62 Citations (Scopus)

Abstract

To better understand the role of germline BRCA mutations in ovarian cancer in Ashkenazi Jews, we tested 29 consecutive patients admitted to our service for the three mutations common in this ethnic group. These mutations are 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2. Six patients had both breast and ovarian cancer, and 23 had ovarian cancer only. In the first group, all women had germline mutations, 2 with each mutation. Of 23 ovarian cancer patients, 11 were carriers (48%): 6 of 185delAG, 2 of 5382insC, and 3 of 6174delT. Regarding family history, of 13 women with no family history, 3 (23%) were carriers. Of 10 women with any family history of breast or ovarian cancer, 8 (80%) were carriers. We discuss possible explanations for this surprisingly high carrier rate, including a high proportion of familial disease coupled with lack of adequate family history, lower penetrance than previously expected, or increasing penetrance in recent generations due to nongenetic factors. Our data suggest that genetic testing is merited in all Ashkenazi women with ovarian cancer, regardless of family history.

Original languageEnglish (US)
Pages (from-to)123-126
Number of pages4
JournalGynecologic oncology
Volume67
Issue number2
DOIs
StatePublished - Nov 1997

Fingerprint

Germ-Line Mutation
Ovarian Neoplasms
Penetrance
Mutation
Breast Neoplasms
Jews
Genetic Testing
Ethnic Groups

ASJC Scopus subject areas

  • Oncology
  • Obstetrics and Gynecology

Cite this

High frequency of BRCA1 and BRCA2 germline mutations in Ashkenazi Jewish ovarian cancer patients, regardless of family history. / Beller, Uziel; Halle, David; Catane, Raphael; Kaufman, Bella; Hornreich, Gila; Levy-Lahad, Ephrat.

In: Gynecologic oncology, Vol. 67, No. 2, 11.1997, p. 123-126.

Research output: Contribution to journalArticle

Beller, Uziel ; Halle, David ; Catane, Raphael ; Kaufman, Bella ; Hornreich, Gila ; Levy-Lahad, Ephrat. / High frequency of BRCA1 and BRCA2 germline mutations in Ashkenazi Jewish ovarian cancer patients, regardless of family history. In: Gynecologic oncology. 1997 ; Vol. 67, No. 2. pp. 123-126.
@article{13a2b8c2e13546058b5088f316d6f3c3,
title = "High frequency of BRCA1 and BRCA2 germline mutations in Ashkenazi Jewish ovarian cancer patients, regardless of family history",
abstract = "To better understand the role of germline BRCA mutations in ovarian cancer in Ashkenazi Jews, we tested 29 consecutive patients admitted to our service for the three mutations common in this ethnic group. These mutations are 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2. Six patients had both breast and ovarian cancer, and 23 had ovarian cancer only. In the first group, all women had germline mutations, 2 with each mutation. Of 23 ovarian cancer patients, 11 were carriers (48{\%}): 6 of 185delAG, 2 of 5382insC, and 3 of 6174delT. Regarding family history, of 13 women with no family history, 3 (23{\%}) were carriers. Of 10 women with any family history of breast or ovarian cancer, 8 (80{\%}) were carriers. We discuss possible explanations for this surprisingly high carrier rate, including a high proportion of familial disease coupled with lack of adequate family history, lower penetrance than previously expected, or increasing penetrance in recent generations due to nongenetic factors. Our data suggest that genetic testing is merited in all Ashkenazi women with ovarian cancer, regardless of family history.",
author = "Uziel Beller and David Halle and Raphael Catane and Bella Kaufman and Gila Hornreich and Ephrat Levy-Lahad",
year = "1997",
month = "11",
doi = "10.1006/gyno.1997.4844",
language = "English (US)",
volume = "67",
pages = "123--126",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - High frequency of BRCA1 and BRCA2 germline mutations in Ashkenazi Jewish ovarian cancer patients, regardless of family history

AU - Beller, Uziel

AU - Halle, David

AU - Catane, Raphael

AU - Kaufman, Bella

AU - Hornreich, Gila

AU - Levy-Lahad, Ephrat

PY - 1997/11

Y1 - 1997/11

N2 - To better understand the role of germline BRCA mutations in ovarian cancer in Ashkenazi Jews, we tested 29 consecutive patients admitted to our service for the three mutations common in this ethnic group. These mutations are 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2. Six patients had both breast and ovarian cancer, and 23 had ovarian cancer only. In the first group, all women had germline mutations, 2 with each mutation. Of 23 ovarian cancer patients, 11 were carriers (48%): 6 of 185delAG, 2 of 5382insC, and 3 of 6174delT. Regarding family history, of 13 women with no family history, 3 (23%) were carriers. Of 10 women with any family history of breast or ovarian cancer, 8 (80%) were carriers. We discuss possible explanations for this surprisingly high carrier rate, including a high proportion of familial disease coupled with lack of adequate family history, lower penetrance than previously expected, or increasing penetrance in recent generations due to nongenetic factors. Our data suggest that genetic testing is merited in all Ashkenazi women with ovarian cancer, regardless of family history.

AB - To better understand the role of germline BRCA mutations in ovarian cancer in Ashkenazi Jews, we tested 29 consecutive patients admitted to our service for the three mutations common in this ethnic group. These mutations are 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2. Six patients had both breast and ovarian cancer, and 23 had ovarian cancer only. In the first group, all women had germline mutations, 2 with each mutation. Of 23 ovarian cancer patients, 11 were carriers (48%): 6 of 185delAG, 2 of 5382insC, and 3 of 6174delT. Regarding family history, of 13 women with no family history, 3 (23%) were carriers. Of 10 women with any family history of breast or ovarian cancer, 8 (80%) were carriers. We discuss possible explanations for this surprisingly high carrier rate, including a high proportion of familial disease coupled with lack of adequate family history, lower penetrance than previously expected, or increasing penetrance in recent generations due to nongenetic factors. Our data suggest that genetic testing is merited in all Ashkenazi women with ovarian cancer, regardless of family history.

UR - http://www.scopus.com/inward/record.url?scp=0031281949&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031281949&partnerID=8YFLogxK

U2 - 10.1006/gyno.1997.4844

DO - 10.1006/gyno.1997.4844

M3 - Article

C2 - 9367693

AN - SCOPUS:0031281949

VL - 67

SP - 123

EP - 126

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

IS - 2

ER -